News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
710,366 Results
Type
Article (42065)
Company Profile (295)
Press Release (668006)
Section
Business (210244)
Career Advice (2086)
Deals (36607)
Drug Delivery (100)
Drug Development (82914)
Employer Resources (172)
FDA (16517)
Job Trends (15372)
News (355644)
Policy (33848)
Tag
Academia (2574)
Alliances (51288)
Alzheimer's disease (1317)
Approvals (16481)
Artificial intelligence (193)
Bankruptcy (364)
Best Places to Work (11754)
Biotechnology (188)
Breast cancer (217)
Cancer (1617)
Cardiovascular disease (129)
Career advice (1744)
CAR-T (113)
Cell therapy (326)
Clinical research (66588)
Collaboration (622)
Compensation (317)
COVID-19 (2627)
C-suite (144)
Data (1521)
Diabetes (197)
Diagnostics (6318)
Earnings (86814)
Employer resources (149)
Events (113385)
Executive appointments (529)
FDA (17346)
Funding (555)
Gene therapy (235)
GLP-1 (669)
Government (4469)
Healthcare (18924)
Infectious disease (2725)
Inflammatory bowel disease (118)
Interviews (320)
IPO (16698)
Job creations (4053)
Job search strategy (1489)
Layoffs (452)
Legal (8344)
Lung cancer (236)
Manufacturing (231)
Medical device (13330)
Medtech (13335)
Mergers & acquisitions (20206)
Metabolic disorders (533)
Neuroscience (1709)
NextGen: Class of 2025 (6632)
Non-profit (4521)
Northern California (1931)
Obesity (305)
Opinion (213)
Patents (142)
People (58678)
Phase I (20642)
Phase II (29299)
Phase III (21958)
Pipeline (641)
Postmarket research (2653)
Preclinical (8744)
Radiopharmaceuticals (245)
Rare diseases (313)
Real estate (6245)
Regulatory (22683)
Research institute (2360)
Resumes & cover letters (358)
Southern California (1672)
Startups (3717)
United States (17416)
Vaccines (609)
Weight loss (216)
Date
Last 7 days (632)
Last 30 days (2609)
Last 365 days (35172)
2025 (2698)
2024 (35770)
2023 (40630)
2022 (51797)
2021 (56329)
2020 (54794)
2019 (47400)
2018 (35771)
2017 (33137)
2016 (32662)
2015 (38615)
2014 (32516)
2013 (27630)
2012 (29729)
2011 (30487)
2010 (28497)
Location
Africa (776)
Arizona (213)
Asia (40309)
Australia (6455)
California (4428)
Canada (1610)
China (378)
Colorado (201)
Connecticut (211)
Europe (85846)
Florida (636)
Georgia (154)
Illinois (442)
Indiana (257)
Maryland (706)
Massachusetts (3446)
Michigan (190)
Minnesota (323)
New Jersey (1259)
New York (1272)
North Carolina (817)
Northern California (1931)
Ohio (161)
Pennsylvania (1032)
South America (1159)
Southern California (1672)
Texas (653)
Utah (130)
Washington State (442)
710,366 Results for "semnur pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Announces Today the Filing of a Registration Statement on Form S-4 by Denali Capital Acquisition Corp. with the Securities and Exchange Commission Relating to the Previously Announced Proposed Business Combination Between Semnur and Denali
November 7, 2024
·
13 min read
Press Releases
Scilex Holding Company Announces Change in Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex’s Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from November 7, 2024 to January 28, 2025
December 30, 2024
·
7 min read
Press Releases
Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Provides Timing to File in October 2024 a Registration Statement on Form S-4 with the SEC relating to the Previously Announced Proposed Business Combination Between Semnur and Denali with a Pre-Transaction Equity Value of $2.5 Billion
October 16, 2024
·
13 min read
Press Releases
Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Announce Signing of a Merger Agreement for a proposed Business Combination, Providing for a Pre-Transaction Equity Value of Semnur of $2.5 Billion
September 3, 2024
·
17 min read
Press Releases
Scilex Holding Company sets November 7, 2024 as the Record Date for a Dividend of Preferred Stock Exchangeable for up to 10% of Scilex’s Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary
October 28, 2024
·
14 min read
Business
Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Enter into a Letter of Intent for a Proposed Business Combination
July 3, 2024
·
20 min read
Press Releases
Scilex Holding Company Announces Extension of the Maturity Date of its Secured Promissory Note Issued to Oramed Pharmaceuticals Inc. to December 31, 2025
January 21, 2025
·
6 min read
Press Releases
Conduit Pharmaceuticals Inc. Announces Reverse Stock Split
January 23, 2025
·
5 min read
Press Releases
Immedica to Acquire Biopharmaceutical Company Marinus Pharmaceuticals, Inc.
December 30, 2024
·
11 min read
Press Releases
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of Binding Term Sheet for $27 Million in Funding for HOPE Clinic Acquisitions and Pharmaceutical Operations
January 7, 2025
·
8 min read
1 of 71,037
Next
